For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260304:nRSD2087Va&default-theme=true
RNS Number : 2087V Animalcare Group PLC 04 March 2026
4 March 2026
Animalcare Group plc
("Animalcare", the "Company", or together with its subsidiaries, the "Group")
Capital Markets Event: In Good Health
Delivering the next stage of growth, to achieve 2030 revenue and EBITDA
ambitions
Animalcare Group Plc (AIM: ANCR), the international animal health business, is
today hosting a Capital Markets Event to provide greater insight into the
three pillars of its growth strategy and outline opportunities to accelerate
its growth in the near to medium-term.
Over the past five years, Animalcare has undergone a period of transformation,
resulting in a rationalised portfolio of higher quality offerings, expanded
geographic reach and strengthened balance sheet. More recently, this progress
has been accelerated by the earnings accretive acquisition of Randlab, the
Australia-based Equine business, and the development of a growing R&D
pipeline with transformative growth potential.
As part of today's presentations, the Group will introduce new medium-term
financial ambitions, including reaching around £150m of revenue with a
pathway to 25% EBITDA margin by 2030. Leveraging Animalcare's established and
strong commercial platform, these ambitions reflect opportunities to
accelerate organic growth in the near to medium-term through investing in
activities such as expanding the dental franchise, improving manufacturing
efficiency and pursuing selective and accretive M&A.
No updates on current trading will be provided during the meeting.
Details of the presentation
The Capital Markets Event will take place today from 2pm at Stifel's offices
in London for pre-registered attendees. Hosted by Animalcare's CEO, Jennifer
Winter, and CFO, Chris Brewster, the event will feature presentations from the
senior management team, followed by an opportunity to ask questions. Should
you wish to attend, please contact animalcare@almastrategic.com for further
details.
A copy of the presentation will be made available on the Company's website
following the event, with a full replay of the event available in the coming
days.
This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the
European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this
announcement, this inside information is now considered to be in the public
domain. The person responsible for arranging for the release of this
announcement on behalf of the Company is Chris Brewster, CFO.
For more information, please contact:
Animalcare Group Plc +44 (0)1904 487 687
Jenny Winter, Chief Executive Officer
Chris Brewster, Chief Financial Officer
Media/investor relations
communications@animalcaregroup.com
Stifel (Nominated Advisor & Joint Broker) Tel: +44 (0)20 7710 7600
Ben Maddison
Francis North
Jason Grossman
Panmure Liberum (Joint Broker) +44 (0)20 7886 2500
Corporate Finance
Emma Earl, Freddy Crossley
Corporate Banking
Rupert Dearden
Alma Strategic Communications +44 (0)20 3405 0205
Caroline Forde animalcare@almastrategic.com (mailto:animalcare@almastrategic.com)
Kinvara Verdon
Rose Docherty
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and
marketing organisation. Animalcare operates in seven European countries as
well as Australia and New Zealand and exports to approximately 40 countries in
Europe and worldwide. The Group is focused on bringing new and innovative
products to market through its own development pipeline, partnerships and via
acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
(http://www.animalcaregroup.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCFZGGFLFDGVZM
Copyright 2019 Regulatory News Service, all rights reserved